0001127602-16-044806.txt : 20160303
0001127602-16-044806.hdr.sgml : 20160303
20160303160713
ACCESSION NUMBER: 0001127602-16-044806
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160301
FILED AS OF DATE: 20160303
DATE AS OF CHANGE: 20160303
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CONMED CORP
CENTRAL INDEX KEY: 0000816956
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 160977505
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502
BUSINESS PHONE: 315-624-3215
MAIL ADDRESS:
STREET 1: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Beyer Pat
CENTRAL INDEX KEY: 0001627985
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-16093
FILM NUMBER: 161481188
MAIL ADDRESS:
STREET 1: C/O CONMED CORPORATION
STREET 2: 525 FRENCH ROAD
CITY: UTICA
STATE: NY
ZIP: 13502
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2016-03-01
0000816956
CONMED CORP
CNMD
0001627985
Beyer Pat
C/O CONMED CORPORATION
525 FRENCH ROAD
UTICA
NY
13502
1
President - International
Common Stock
2016-03-01
4
M
0
675
0
A
5675
D
Common Stock
2016-03-01
4
F
0
369
39.87
D
5306
D
Rsus (restricted Stock Units)
0
2016-03-01
4
M
0
675
0
D
2025-02-27
Common Stock
675
2025
D
Rsus (restricted Stock Units)
0
2016-03-01
4
A
0
2900
0
A
2026-03-01
Common Stock
2900
2900
D
Options To Purchase Common Stock
39.87
2016-03-01
4
A
0
55300
0
A
2026-03-01
Common Stock
55300
55300
D
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
The incentive stock options ("ISOs") were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period
/s/ Sarah M. Oliker for Pat Beyer by Power of Attorney
2016-03-03
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POA
EXHIBIT 24
POWER OF ATTORNEY
Know all by these presents, that the undersigned hereby constitutes and
appoints each of Daniel S. Jonas and Sarah M. Oliker, signing singly, the
undersigned's true and lawful attorney-in-fact to:
(1) prepare, execute in the undersigned's name and on the
undersigned's behalf, and submit to the U.S. Securities and Exchange
Commission (the "SEC") a Form ID, including amendments thereto,
and any other documents necessary or appropriate to obtain codes and
passwords enabling the undersigned to make electronic filings with the SEC
of reports required by Section 16(a) of the Securities Exchange Act
of 1934 or any rule or regulation of the SEC;
(2) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer and/or director of (the "Company"), Forms 3, 4, and 5
in accordance with Section 16(a) of the Securities Exchange Act of 1934 and
the rules thereunder, and any other forms or reports the undersigned may be
required to file in connection with the undersigned 's ownership,
acquisition, or disposition of securities of the Company;
(3) do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and execute
any such Form 3, 4, or 5, or other form or report, including executing Form
144s, lock-ups, internal corporate forms for the exercise of SARs or options
and the like, and to timely file such form or report with the U nited States
Securities
and Exchange Commission and any stock exchange or similar authority; and
(4) take any other action of any type whatsoever in connection
with the foregoing wh ich, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required by,
the undersigned, it being understood that the documents executed by
such attorney-in-fact on behalf of the undersigned pursuant to this
Power of Attorney shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such attorney-in-fact's
discretion.
The undersigned hereby grants to each such attorney-in-fact full
power and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full
power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute
or substitutes, shall lawfully do or cause to be done by virtue of this
power of attorney and the rights and powers herein granted . The
undersigned acknowledges that the foregoing attorneys-in-fact, in serving
in such capacity at the request of the undersigned, are not assuming, nor is
the
the Company assuming, any of the undersigned's responsibilities to comply
with Section 16 of the Securities Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect
to the undersigned 's holdings of and transactions in securities issued by
the Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, the undersigned has caused this Power of
Attorney to be executed as of this 10th day of December 2014.
/s/Pat Beyer
Signature
/s/ Pat Beyer
Print Name